#United States #New York #Securities Class Action #Levi Korsinsky #Park Ha Technology

Overview of the Park Ha Class Action Lawsuit

Levi & Korsinsky, LLP has recently notified investors of Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) regarding a significant securities class action lawsuit. This legal matter has arisen due to allegations that the company's financial disclosures included misleading information, ultimately leading to catastrophic stock declines for its investors. As a prospective investor or shareholder, it's vital to understand the implications of this lawsuit which could affect your ability to recoup potential losses.

Key Details of the Lawsuit

The lawsuit targets investors who purchased securities of BYAH between December 27, 2024, and July 8, 2025. On July 8, 2025, BYAH shares plummeted by approximately 93%, resulting in a massive reduction of over $1 billion in market capitalization. If you invested during this period, you could be eligible to recover your losses. The deadline for lead plaintiffs to step forward is September 28, 2026.

The Role of Xiaoyan Zhu

At the heart of the complaint is the role of Xiaoyan Zhu, who has served as the Chief Financial Officer of BYAH since 2016 and was appointed to the Board of Directors in July 2024. Zhu signed the December 2024 registration statement and oversaw reports that included exaggerated financial results. The class action asserts that the reports misrepresented the company's franchise operations, failing to disclose elements that led to the vulnerability of BYAH shares to manipulation. This failure is particularly important for investors to scrutinize, as it may indicate serious negligence or wrongdoing from those in leadership positions.

Allegations Against Zhu

The lawsuit specifically lists Zhu’s actions during the operational period:

• - Oversaw financial reporting and disclosures attached to the company's IPO.
• - Signed registration statements that misrepresented the public float and operations of the company.
• - Did not correct misleading information about extreme volatility in the stock price.
• - Was privy to non-public information regarding the company's financial health and was among the responsible officers.

Understanding the Legal Context

This legal action is grounded in U.S. securities law as per Sections 11, 12, and 15 of the Securities Act and Sections 10(b) and 20(a) of the Exchange Act. These provisions aim to protect investors by holding directors and executives accountable for their disclosures. Hence, if proven, Zhu and other officers could be personally liable for investor losses.

Potential Impact on Investors

For shareholders, this class action offers a chance to seek accountability and potentially recover losses experienced due to the misleading information circulated during the IPO period. Levi & Korsinsky's long-standing reputation and success in shareholder litigation provide a layer of reassurance for affected investors.

Frequently Asked Questions

• - Who are the defendants? The lawsuit names Park Ha Biological Technology Co., its founders, and directors as defendants.
• - What are the specific allegations? Misleading statements about the business and promotional tactics used by the company, including a lack of transparency over the stock's accessibility to manipulation.
• - What is the next step for investors? Interested investors should act quickly to secure their position as lead plaintiffs by submitting appropriate documentation including trading records and evidence of their purchases.

Conclusion

Understanding the ramifications of the Park Ha class action lawsuit is critical for any shareholders involved in this case. Those who acquired shares during the class period may find an opportunity for recovery, but prompt action is necessary to meet the deadline set by the court. Levi & Korsinsky is committed to representing the interests of investors who have seen their holdings drastically devalued due to alleged corporate mismanagement. For further assistance, investors can reach out to Levi & Korsinsky directly to explore their rights and options in this unfolding legal scenario.